HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"),
the nation's largest health savings account ("HSA") custodian,
today announced its HSAs, HSA Assets and Total Accounts as of its
fiscal year ended January 31, 2025. The Company also affirmed
its guidance for fiscal 2025 and 2026, provided an updated HSA cash
repricing schedule, and announced upcoming events and
presentations.
The total number of HSAs as of January 31, 2025 was 9.9
million, an increase of 14%, from 8.7 million as of
January 31, 2024. The Company closed its fiscal year 2025 with
17.0 million Total Accounts, an increase of 9%, from 15.7 million
as of January 31, 2024. HSA Assets grew to $32.1 billion as of
January 31, 2025, an increase of 27% from $25.2 billion a year
earlier.
"Our ongoing investments in innovations helped Team Purple drive
record results, breaking the one million new HSAs from sales
ceiling and adding nearly $7 billion in HSA Assets in fiscal 2025,"
said Scott Cutler, President and CEO of HealthEquity. "As we launch
into fiscal 2026, we are focused on accelerating and extending our
mission’s reach to empower more healthcare consumers."
Total Accounts (unaudited)
(in thousands, except percentages) |
January 31, 2025 |
January 31, 2024 |
% Change |
HSAs |
9,889 |
8,692 |
14% |
New HSAs from sales -
Quarter-to-date |
471 |
497 |
(5)% |
New HSAs from sales -
Year-to-date |
1,040 |
949 |
10% |
New HSAs from acquisitions -
Year-to-date |
616 |
— |
* |
HSAs with investments |
753 |
610 |
23% |
CDBs |
7,144 |
7,006 |
2% |
Total Accounts |
17,033 |
15,698 |
9% |
Average Total Accounts -
Quarter-to-date |
16,677 |
15,318 |
9% |
Average
Total Accounts - Year-to-date |
16,302 |
15,105 |
8% |
|
|
|
|
* Not meaningful
HSA Assets (unaudited)
(in millions, except percentages) |
January 31, 2025 |
|
January 31, 2024 |
|
% Change |
HSA cash |
$ |
17,435 |
|
$ |
15,006 |
|
16% |
HSA investments |
|
14,676 |
|
|
10,208 |
|
44% |
Total HSA Assets |
|
32,111 |
|
|
25,214 |
|
27% |
Average daily HSA cash -
Quarter-to-date |
|
16,634 |
|
|
14,210 |
|
17% |
Average
daily HSA cash - Year-to-date |
|
16,206 |
|
|
14,071 |
|
15% |
|
|
|
|
|
|
|
|
The following table summarizes the amount of HSA cash expected
to reprice by fiscal year and the respective average annualized
yield as of January 31, 2025:
Year ending January 31, (in billions, except
percentages) |
HSA cash expected to reprice |
|
Average annualized yield |
2026 |
$ |
2.3 |
|
2.5% |
2027 |
|
4.1 |
|
1.9% |
2028 |
|
2.1 |
|
4.0% |
2029 |
|
1.5 |
|
3.6% |
Thereafter |
|
6.6 |
|
4.4% |
Total (1) |
$ |
16.6 |
|
3.4% |
(1) Excludes $0.8 billion of HSA cash held in
floating-rate contracts as of January 31, 2025.
Business outlook
The Company affirmed its previously provided outlook for the
fiscal year ended January 31, 2025 and the fiscal year ending
January 31, 2026. Please see the Company’s press release dated
December 9, 2024 for details.
Upcoming events and presentations
The Company set the date for reporting its fourth quarter and
fiscal year 2025 results.
HealthEquity Fourth Quarter and Fiscal Year End
2025 Results Conference Call |
Date: |
March 18,
2025 |
Time: |
4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time |
Dial-In: |
1-844-481-2556 (US and Canada) 1-412-317-0560
(International) |
Conference ID: |
HealthEquity |
Webcast: |
ir.healthequity.com |
|
|
The Company also announced that its management team plans to
present and meet with investors at the following conference:
Raymond James 46th Annual Institutional Investors
Conference |
Location: |
JW Marriott
Orlando Great Lakes |
Date: |
March 4, 2025 |
Time: |
1:05 p.m. Eastern Time |
Webcast: |
None |
|
|
About HealthEquity
HealthEquity and its subsidiaries administer HSAs and other
consumer-directed benefits for more than 17 million accounts in
partnership with employers, benefits advisors, and health and
retirement plan providers who share our vision of saving and
improving the lives of healthcare consumers. For more information,
visit www.healthequity.com.
Forward-looking statements
This press release contains and incorporates “forward-looking
statements” within the meaning of the “safe harbor” provisions of
the Private Securities Litigation Reform Act of 1995, including but
not limited to, statements regarding our industry, business
strategy, plans, goals and expectations concerning our markets and
market position, product expansion, future operations, expenses and
other results of operations, revenue, margins, profitability,
acquisition synergies, future efficiencies, tax rates, capital
expenditures, liquidity and capital resources and other financial
and operating information. When used in this discussion, the words
“may,” “believes,” “intends,” “seeks,” “aims,” “anticipates,”
“plans,” “estimates,” “expects,” “should,” “assumes,” “continues,”
“could,” “will,” “future” and the negative of these or similar
terms and phrases are intended to identify forward-looking
statements in this press release.
Forward-looking statements reflect our current expectations
regarding future events, results or outcomes. These expectations
may or may not be realized. Although we believe the expectations
reflected in the forward-looking statements are reasonable, we can
give you no assurance these expectations will prove to be correct.
Some of these expectations may be based upon assumptions, data or
judgments that prove to be incorrect. Actual events, results and
outcomes may differ materially from our expectations due to a
variety of known and unknown risks, uncertainties and other
factors. Although it is not possible to identify all of these risks
and factors, they include, among others, risks related to the
following:
- our ability to adequately place and safeguard our custodial
assets, or the failure of any of our depository or insurance
company partners;
- our ability to compete effectively in a rapidly evolving
healthcare and benefits administration industry;
- our dependence on the continued availability and benefits of
tax-advantaged HSAs and other CDBs;
- risks relating to our recent CEO transition;
- the impact of fraudulent account activity on our reputation and
financial results;
- our ability to successfully identify, acquire and integrate
additional portfolio purchases or acquisition targets;
- the significant competition we face and may face in the future,
including from those with greater resources than us;
- our reliance on the availability and performance of our
technology and communications systems;
- recent and potential future cybersecurity breaches of our
technology and communications systems and other data interruptions,
including resulting costs and liabilities, reputational damage and
loss of business;
- the current uncertain healthcare environment, including changes
in healthcare programs and expenditures and related
regulations;
- our ability to comply with current and future privacy,
healthcare, tax, ERISA, investment adviser and other laws
applicable to our business;
- our reliance on partners and third-party vendors for
distribution and important services;
- our ability to develop and implement updated features for our
technology platforms and communications systems; and
- our reliance on our management team and key team members.
For a detailed discussion of these and other risk factors,
please refer to the risks detailed in our filings with the
Securities and Exchange Commission, including, without limitation,
our Annual Report on Form 10-K for the fiscal year ended January
31, 2024, our Quarterly Reports on Form 10-Q for the quarters ended
July 31, 2024, and October 31, 2024, and other periodic and current
reports. Past performance is not necessarily indicative of future
results. We undertake no intention or obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise. Forward-looking statements
should not be relied upon as representing our views as of any date
subsequent to the date of this press release.
Investor Relations ContactRichard
Putnam801-727-1000rputnam@healthequity.com
Certain terms
Term |
Definition |
HSA |
A financial account through which
consumers spend and save long-term for healthcare on a
tax-advantaged basis. |
CDB |
Consumer-directed benefits
offered by employers, including flexible spending and health
reimbursement arrangements (“FSAs” and “HRAs”), Consolidated
Omnibus Budget Reconciliation Act (“COBRA”) administration,
commuter and other benefits. |
HSA member |
Consumers with HSAs that we
serve. |
Total HSA Assets |
HSA members’ custodial cash
assets held by our federally insured depository partners and our
insurance company partners. Total HSA Assets also includes HSA
members' investments in mutual funds through our custodial
investment fund partner. |
Total Accounts |
The sum of HSAs and CDBs on our platforms. |
HealthEquity (NASDAQ:HQY)
Historical Stock Chart
From Jan 2025 to Mar 2025
HealthEquity (NASDAQ:HQY)
Historical Stock Chart
From Feb 2024 to Mar 2025